{"id":"https://openalex.org/W2243389547","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.7582","title":"Systemic gene therapy with tumor suppressor FUS1-nanoparticles for recurrent/metastatic lung cancer.","display_name":"Systemic gene therapy with tumor suppressor FUS1-nanoparticles for recurrent/metastatic lung cancer.","publication_year":2010,"publication_date":"2010-05-20","ids":{"openalex":"https://openalex.org/W2243389547","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.7582","mag":"2243389547"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2010.28.15_suppl.7582","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.7582","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.7582","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077763767","display_name":"Charles Lu","orcid":"https://orcid.org/0000-0003-3450-1682","observed_orcids":["https://orcid.org/0000-0003-3450-1682"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Lu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100609224","display_name":"David J. Stewart","orcid":"https://orcid.org/0000-0002-0184-7946","observed_orcids":["https://orcid.org/0000-0002-0184-7946"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. J. Stewart","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072201890","display_name":"Linlin Ji","orcid":"https://orcid.org/0000-0002-7949-7034","observed_orcids":["https://orcid.org/0000-0002-7949-7034"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Ji","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068736204","display_name":"Rajagopal Ramesh","orcid":"https://orcid.org/0000-0002-7658-5338","observed_orcids":["https://orcid.org/0000-0002-7658-5338"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Ramesh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046839542","display_name":"Gauri Jayachandran","orcid":"https://orcid.org/0009-0008-0849-040X","observed_orcids":["https://orcid.org/0009-0008-0849-040X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Jayachandran","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112827538","display_name":"J. J. Erasmus","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. J. Erasmus","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109388216","display_name":"J. Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111911122","display_name":"N S Templeton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N. S. Templeton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112080682","display_name":"J. McMannis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. D. McMannis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5027152610","display_name":"Jack A. Roth","orcid":"https://orcid.org/0000-0002-8955-1313","observed_orcids":["https://orcid.org/0000-0002-8955-1313"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. A. Roth","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"28","issue":"15_suppl","first_page":"7582","last_page":"7582"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9067000150680542,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.9067000150680542,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.048700001090765,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.011800000444054604,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fus1","display_name":"FUS1","score":0.8259999752044678},{"id":"https://openalex.org/keywords/tumor-suppressor-gene-therapy","display_name":"tumor suppressor gene therapy","score":0.8709999918937683},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.7639999985694885},{"id":"https://openalex.org/keywords/metastatic-lung-cancer","display_name":"metastatic lung cancer","score":0.9520000219345093},{"id":"https://openalex.org/keywords/recurrent-lung-cancer","display_name":"recurrent lung cancer","score":0.9769999980926514},{"id":"https://openalex.org/keywords/intravenous-gene-delivery","display_name":"intravenous gene delivery","score":0.5839999914169312},{"id":"https://openalex.org/keywords/apaf-1","display_name":"Apaf-1","score":0.6420000195503235},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.5580000281333923},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7239999771118164},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8560000061988831},{"id":"https://openalex.org/keywords/hypophosphatemia","display_name":"hypophosphatemia","score":0.9430000185966492},{"id":"https://openalex.org/keywords/fever","display_name":"fever","score":0.39800000190734863},{"id":"https://openalex.org/keywords/platinum-refractory-disease","display_name":"platinum-refractory disease","score":0.6129999756813049},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.48500001430511475}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9043124914169312},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5759134292602539},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5580356121063232},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4913701117038727},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.4603900611400604},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4462225139141083},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.429002046585083},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.42360588908195496},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3490987718105316},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3306465744972229}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2010.28.15_suppl.7582","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.7582","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.7582","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2226656885","https://openalex.org/W2784416871","https://openalex.org/W2071272462","https://openalex.org/W1973568055","https://openalex.org/W1996487606","https://openalex.org/W1964602635","https://openalex.org/W3161495007","https://openalex.org/W1994846342","https://openalex.org/W2010542690","https://openalex.org/W4236168829"],"abstract_inverted_index":{"7582":[0],"Background:":[1],"The":[2,152,302],"tumor":[3,227,300],"suppressor":[4],"gene":[5,296],"FUS1":[6,16,35,246,264],"is":[7,219,308,325],"frequently":[8],"inactivated":[9],"early":[10],"in":[11,19,47,170,268,276,291,298,321],"lung":[12],"cancer":[13,20,43],"(LC)":[14],"development.":[15],"mediates":[17],"apoptosis":[18],"cells":[21,25,44],"but":[22,274],"not":[23,275],"normal":[24],"through":[26],"its":[27],"interaction":[28],"with":[29,55,60,65,92,138,191,202,294,323],"Apaf1.":[30],"DOTAP:cholesterol":[31],"nanoparticles":[32],"encapsulating":[33],"a":[34,171,207,244,319],"expression":[36,265,297],"plasmid":[37,245,263],"(DOTAP:chol-FUS1)":[38],"showed":[39],"selective":[40],"uptake":[41],"by":[42,282],"and":[45,140,143,148,166,197,223,234,279],"activity":[46],"mouse":[48],"xenograft":[49],"metastatic":[50],"LC":[51,57,292],"models.":[52],"Methods:":[53],"Patients":[54,72],"recurrent/metastatic":[56],"previously":[58],"treated":[59,64,87,116],"platinum-based":[61],"chemotherapy":[62,111],"were":[63,156,187,229],"escalating":[66],"doses":[67,74,186],"of":[68,100,131,159,176,206,257,262,270],"intravenous":[69],"DOTAP:chol-FUS1.":[70],"Results:":[71],"received":[73,106,182],"ranging":[75],"from":[76,231],"0.01-0.09":[77],"mg/kg":[78,310],"at":[79,88],"3":[80,312],"week":[81],"intervals.":[82],"Thirty":[83],"patients":[84,94,115,136,180,218,293],"have":[85],"been":[86],"6":[89,232,271],"dose":[90,174],"levels,":[91],"all":[93,119,217],"evaluable":[95,188],"for":[96,189,216,304],"the":[97,134],"primary":[98],"endpoint":[99],"cycle":[101],"1":[102],"toxicity.":[103],"70%":[104],"had":[105,204],"2":[107,124,144,157],"or":[108,125,184,330,334],"more":[109,185],"prior":[110],"regimens.":[112],"Among":[113,133],"4":[114,120],"without":[117],"premedications,":[118],"developed":[121,146],"grade":[122],"(G)":[123],"higher":[126],"fevers":[127],"within":[128],"24":[129,224],"hours":[130],"treatment.":[132],"26":[135],"premedicated":[137],"dexamethasone":[139],"diphenhydramine,":[141],"7":[142],"subjects":[145],"G1":[147],"G2":[149],"fever,":[150],"respectively.":[151],"only":[153],"dose-limiting":[154],"toxicities":[155],"episodes":[158],"transient":[160],"G3":[161],"hypophosphatemia":[162],"(dose":[163],"levels":[164],"0.06":[165,177,309],"0.09":[167],"mg/kg),":[168],"resulting":[169],"maximum":[172],"tolerated":[173],"(MTD)":[175],"mg/kg.":[178],"Twenty-two":[179],"who":[181],"two":[183],"response,":[190],"5":[192,269],"achieving":[193],"stable":[194],"disease":[195],"(SD)":[196],"17":[198],"progressing.":[199],"One":[200],"patient":[201],"SD":[203],"evidence":[205],"metabolic":[208],"response":[209],"on":[210,251,315],"PET":[211],"imaging.":[212],"Median":[213],"survival":[214],"time":[215,237,256],"9.1":[220],"months.":[221],"Pre":[222],"hour":[225],"posttreatment":[226,272,299],"biopsies":[228],"obtained":[230],"patients,":[233],"quantitative":[235],"real":[236],"reverse":[238],"transcriptase":[239],"PCR":[240],"(RT-PCR)":[241],"analysis":[242],"using":[243],"sequence-specific":[247],"probe":[248],"was":[249,266],"performed":[250],"these":[252],"paired-samples":[253],"blinded":[254],"to":[255],"biopsy.":[258],"A":[259],"high":[260],"level":[261],"detected":[267],"samples":[273,278],"pretreatment":[277],"negative":[280],"controls":[281],"RT-PCR.":[283],"Conclusions:":[284],"DOTAP:chol-FUS1":[285],"can":[286],"be":[287],"safely":[288],"administered":[289],"intravenously":[290],"demonstrable":[295],"biopsies.":[301],"MTD":[303],"phase":[305],"II":[306],"testing":[307],"every":[311],"weeks.":[313],"Based":[314],"promising":[316],"preclinical":[317],"data,":[318],"trial":[320],"combination":[322],"erlotinib":[324],"planned.":[326],"Author":[327],"Disclosure":[328],"Employment":[329],"Leadership":[331],"Position":[332],"Consultant":[333],"Advisory":[335],"Role":[336],"Stock":[337],"Ownership":[338],"Honoraria":[339],"Research":[340],"Funding":[341],"Expert":[342],"Testimony":[343],"Other":[344],"Remuneration":[345],"Introgen":[346],"Therapeutics":[347]},"counts_by_year":[{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}